The Bauhinia Foundation Research Centre shares research reports, occasional papers and weekly analyses on topical matters and current affairs in a timely manner. Want to stay connected with us? Please enter your email address.
Hong Kong tycoon Li Ka-shing is optimistic about the potential of synthetic biology, once described it as an ‘extremely disruptive technology’. Li’s investment arm Horizons Ventures has already invested in several synthetic biology startups in recent years, while foreign venture capital community also keeps an eye on it. What is synthetic biology? What are the potential impacts and risks?
The full version of the commentary is in Chinese only.